TRPM4 and colorectal carcinoma: These findings suggest that the loss-of-function variant in TRPM4 leads to disruption of the mucus layer, allowing bacterial penetration into the mucin-protected epithelium, and thus resulting in inflammation and risk of CRC (Figure 6B).